![Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot](https://www.gov.scot/binaries/content/gallery/publications/advice-guidance/2021/03/covid-19-mrna-vaccine-bnt162b2-pfizer-biontech-vaccine-national-protocol/SCT03211431062_g01.gif)
Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot
![Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines - ScienceDirect Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S132389302200048X-ga1.jpg)
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines - ScienceDirect
![Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot](https://www.gov.scot/binaries/content/gallery/publications/advice-guidance/2021/03/covid-19-mrna-vaccine-bnt162b2-pfizer-biontech-vaccine-national-protocol/SCT03211431062_g02.gif)
Annex A: Clinical Information - COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol - gov.scot
![Vaccines | Free Full-Text | SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center Vaccines | Free Full-Text | SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center](https://www.mdpi.com/vaccines/vaccines-09-00560/article_deploy/html/images/vaccines-09-00560-g001-550.jpg)
Vaccines | Free Full-Text | SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center
![Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations](https://www.mdpi.com/vaccines/vaccines-09-00221/article_deploy/html/images/vaccines-09-00221-g002.png)
Vaccines | Free Full-Text | Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
![Annex A: Clinical Information - Coronavirus (COVID-19) vaccine - Comirnaty® (mRNA Vaccine, Pfizer/BioNTech): national protocol - gov.scot Annex A: Clinical Information - Coronavirus (COVID-19) vaccine - Comirnaty® (mRNA Vaccine, Pfizer/BioNTech): national protocol - gov.scot](https://www.gov.scot/binaries/content/gallery/publications/regulation-directive-order/2022/02/comirnaty-covid-19-mrna-vaccine-pfizer-biontech-national-protocol-2/SCT012220312612_g01.png)
Annex A: Clinical Information - Coronavirus (COVID-19) vaccine - Comirnaty® (mRNA Vaccine, Pfizer/BioNTech): national protocol - gov.scot
![Frontiers | Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose Frontiers | Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose](https://www.frontiersin.org/files/Articles/825164/falgy-03-825164-HTML/image_m/falgy-03-825164-g001.jpg)
Frontiers | Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose
![COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI) | Allergy, Asthma & Clinical Immunology | Full Text COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI) | Allergy, Asthma & Clinical Immunology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13223-021-00529-2/MediaObjects/13223_2021_529_Fig1_HTML.png)